Explore more topics
SEC reporting owner

14159 capital (GP), LLC SEC insider disclosures

Explore 14159 capital (GP), LLC's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-15T08:02:39.132Z

Reporting owner CIK
0001317493
Issuers
18
Coverage
unverified
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Show the table · 18 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

Ardea Biosciences, Inc./DE0001103390IBPI, RDEANoYes
VIROPHARMA INC0000946840VPHMNoNo
IDERA PHARMACEUTICALS, INC.0000861838IDPNoNo
TAPESTRY PHARMACEUTICALS, INC0000891504TPPHNoNo
SEATTLE GENETICS INC /WA0001060736SGENNoYes
GENOMIC HEALTH INC0001131324GHDXNoYes
ALLOS THERAPEUTICS INC0001097264ALTHNoNo
INCYTE CORP0000879169INCYNoYes
Synvista Therapeutics, Inc.0000878903ALTNoNo
BIOCRYST PHARMACEUTICALS INC0000882796BCRXNoNo
AP PHARMA INC /DE/0000818033APPANoNo
AUXILIUM PHARMACEUTICALS INC0001182129AUXLNoNo
ADOLOR CORP0001076167ADLRNoNo
VAXGEN INC0001036968VXGN.OBNoNo
SYNAGEVA BIOPHARMA CORP0000911326TRMS, GEVANoYes
PHARMACYCLICS INC0000949699PCYCNoNo
XOMA Corp0000791908XOMANoNo
TRANZYME INC0001274644TZYMNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Show the table · 0 rows, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

Inspect the coverage status above, the filing availability dates and amendment links when defining a historical signal. Follow the issuer CIK and SEC accession to the source transaction.